BT

Public archive

Bambusa Therapeutics plans an IPO on Nasdaq (26 Oct 2026)

Updated November 5, 2026

As of 26 October 2026, Bambusa Therapeutics plans an IPO on Nasdaq. The offer range is $15-$17.

Event data

Company
Bambusa Therapeutics
Ticker
BBTX
Exchange
Nasdaq
Status
filed
Ipo Date
week of October 26, 2026
Filing Date
2026-10-26
Offer Price Range
$15-$17
Shares Offered
9400000
Amount To Raise
$150 million
Valuation
$837 million (midpoint fully diluted market value)
Underwriters
BofA Securities, Evercore ISI, UBS Investment Bank, Cantor Fitzgerald
Country
United States

Subscribers saw this 8 days earlier.

Source

renaissancecapital.com